HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

golimumab

Golimumab plus MTX effectively reduces the signs and symptoms of RA and is generally well tolerated in patients with an inadequate response to MTX.
Also Known As:
Simponi
Networked: 245 relevant articles (61 outcomes, 93 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Rahman, Mahboob U: 23 articles (01/2014 - 03/2007)
2. Hsia, Elizabeth C: 22 articles (03/2015 - 04/2008)
3. Mack, Michael: 17 articles (03/2015 - 11/2008)
4. van der Heijde, Désirée: 15 articles (04/2015 - 09/2010)
5. Xu, Zhenhua: 15 articles (12/2014 - 03/2007)
6. Xu, Stephen: 14 articles (04/2015 - 06/2010)
7. Hsu, Benjamin: 13 articles (04/2015 - 11/2008)
8. Beutler, Anna: 12 articles (09/2014 - 11/2008)
9. Braun, Jürgen: 11 articles (04/2015 - 11/2008)
10. Matteson, Eric L: 11 articles (01/2015 - 04/2008)

Related Diseases

1. Rheumatoid Arthritis
2. Ulcerative Colitis
3. Psoriatic Arthritis
4. Ankylosing Spondylitis
5. Psoriasis (Pustulosis Palmaris et Plantaris)

Related Drugs and Biologics

1. adalimumab (Humira)
2. infliximab (Remicade)
3. Methotrexate (Mexate)
4. TNFR-Fc fusion protein (etanercept)
5. CDP870
6. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
7. tocilizumab
8. monoclonal antibody CNTO 1275 (CNTO 1275)
9. abatacept (BELATACEPT)
10. vedolizumab

Related Therapies and Procedures

1. Aftercare (After-Treatment)
2. Remission Induction
3. Subcutaneous Injections
4. Investigational Therapies (Experimental Therapy)
5. Stents